TIFFANY JONES: Open Payments
NPI 1558686519 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,861 in 97 payments from 28 companies in 2025. Trend: 2023 $2,633 · 2024 $612 · 2025 $1,861
Food & beverage: $1,861
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $228 |
| ABBVIE INC. | 11 | $201 |
| Incyte Corporation | 3 | $157 |
| AstraZeneca Pharmaceuticals LP | 8 | $144 |
| Celgene Corporation | 10 | $136 |
| PFIZER INC. | 7 | $126 |
| Novartis Pharmaceuticals Corporation | 5 | $95 |
| Genentech USA, Inc. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| ARRAY BIOPHARMA INC | 4 | $68 |
Products named: REBLOZYL, Monjuvi, RYBREVANT, EPKINLY, IMBRUVICA, KISQALI, Padcev, ERLEADA.
Industry payments across NY — which companies pay providers there.
